Suppr超能文献

结核病控制所挽救的生命以及实现降低结核病死亡率 2015 年全球目标的前景。

Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality.

机构信息

World Health Organization, 20 avenue Appia 20, 1211 Geneva 27, Switzerland.

出版信息

Bull World Health Organ. 2011 Aug 1;89(8):573-82. doi: 10.2471/BLT.11.087510. Epub 2011 May 31.

Abstract

OBJECTIVE

To assess whether the global target of halving tuberculosis (TB) mortality between 1990 and 2015 can be achieved and to conduct the first global assessment of the lives saved by the DOTS/Stop TB Strategy of the World Health Organization (WHO).

METHODS

Mortality from TB since 1990 was estimated for 213 countries using established methods endorsed by WHO. Mortality trends were estimated separately for people with and without human immunodeficiency virus (HIV) infection in accordance with the International classification of diseases. Lives saved by the DOTS/Stop TB Strategy were estimated with respect to the performance of TB control in 1995, the year that DOTS was introduced.

FINDINGS

TB mortality among HIV-negative (HIV-) people fell from 30 to 20 per 100,000 population (36%) between 1990 and 2009 and could be halved by 2015. The overall decline (when including HIV-positive [HIV+] people, who comprise 12% of all TB cases) was 19%. Between 1995 and 2009, 49 million TB patients were treated under the DOTS/Stop TB Strategy. This saved 4.6-6.3 million lives, including those of 0.23-0.28 million children and 1.4-1.7 million women of childbearing age. A further 1 million lives could be saved annually by 2015.

CONCLUSION

Improvements in TB care and control since 1995 have greatly reduced TB mortality, saved millions of lives and brought within reach the global target of halving TB deaths by 2015 relative to 1990. Intensified efforts to reduce deaths among HIV+ TB cases are needed, especially in sub-Saharan Africa.

摘要

目的

评估 1990 年至 2015 年期间结核病(TB)死亡率减半的全球目标是否能够实现,并对世界卫生组织(WHO)的直接面视下的短程化疗/终止结核病策略(DOTS/Stop TB Strategy)所挽救的生命进行首次全球评估。

方法

采用 WHO 认可的既定方法,估算了 213 个国家自 1990 年以来的结核病死亡率。根据国际疾病分类,分别估算了有和没有人类免疫缺陷病毒(HIV)感染的人群的死亡率趋势。根据 1995 年 DOTS 的引入情况,即 DOTS 实施的那一年,评估了 DOTS/Stop TB 策略所挽救的生命。

结果

HIV 阴性(HIV-)人群的结核病死亡率从 1990 年的 30/10 万降至 2009 年的 20/10 万(下降 36%),并有望在 2015 年减半。总体下降(包括占所有结核病病例 12%的 HIV 阳性[HIV+]人群)为 19%。在 1995 年至 2009 年期间,有 4900 万结核病患者接受了 DOTS/Stop TB 策略的治疗。这挽救了 460 万至 630 万人的生命,其中包括 23 万至 28 万儿童和 140 万至 170 万育龄妇女。到 2015 年,每年还可再挽救 100 万人的生命。

结论

自 1995 年以来,结核病护理和控制方面的改进大大降低了结核病死亡率,挽救了数百万人的生命,并使 2015 年结核病死亡人数比 1990 年减少一半的全球目标成为可能。需要加强努力,减少 HIV+结核病病例的死亡,特别是在撒哈拉以南非洲。

相似文献

1
Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality.
Bull World Health Organ. 2011 Aug 1;89(8):573-82. doi: 10.2471/BLT.11.087510. Epub 2011 May 31.
5
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.
Arch Intern Med. 2003 May 12;163(9):1009-21. doi: 10.1001/archinte.163.9.1009.
8
[Tuberculosis in Asia].
Kekkaku. 2002 Oct;77(10):693-7.
9
Tuberculosis.
Ann Trop Med Parasitol. 2006 Jul-Sep;100(5-6):415-31. doi: 10.1179/136485906X91477.
10
Counting the lives saved by DOTS in India: a model-based approach.
BMC Med. 2017 Mar 3;15(1):47. doi: 10.1186/s12916-017-0809-5.

引用本文的文献

1
Structural Aspects of DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors.
ACS Med Chem Lett. 2024 Nov 22;15(12):2164-2170. doi: 10.1021/acsmedchemlett.4c00447. eCollection 2024 Dec 12.
2
Incidence of pulmonary tuberculosis under the regular COVID-19 epidemic prevention and control in China.
BMC Infect Dis. 2022 Jul 24;22(1):641. doi: 10.1186/s12879-022-07620-y.
3
Family health and conditional cash transfer in Brazil and its effect on tuberculosis mortality.
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1300-1306. doi: 10.5588/ijtld.17.0907.
4
Evaluation of health-related quality of life in patients with tuberculosis who completed treatment in Kiribati.
J Int Med Res. 2017 Apr;45(2):610-620. doi: 10.1177/0300060517694491. Epub 2017 Mar 16.
5
Counting the lives saved by DOTS in India: a model-based approach.
BMC Med. 2017 Mar 3;15(1):47. doi: 10.1186/s12916-017-0809-5.
8
Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis.
PLoS One. 2016 Aug 18;11(8):e0160481. doi: 10.1371/journal.pone.0160481. eCollection 2016.
9
A tuberculosis nationwide prevalence survey in Gambia, 2012.
Bull World Health Organ. 2016 Jun 1;94(6):433-41. doi: 10.2471/BLT.14.151670. Epub 2016 Apr 21.

本文引用的文献

1
Assessing tuberculosis case fatality ratio: a meta-analysis.
PLoS One. 2011;6(6):e20755. doi: 10.1371/journal.pone.0020755. Epub 2011 Jun 27.
2
Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients.
J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):146-52. doi: 10.1097/QAI.0b013e31821190a3.
4
The effect of tuberculosis on mortality in HIV positive people: a meta-analysis.
PLoS One. 2010 Dec 30;5(12):e15241. doi: 10.1371/journal.pone.0015241.
5
Tuberculosis control is crucial to achieve the MDGs.
Lancet. 2010 Sep 18;376(9745):940-1. doi: 10.1016/S0140-6736(10)61428-6.
8
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.
Lancet. 2010 May 22;375(9728):1830-43. doi: 10.1016/S0140-6736(10)60410-2.
10
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5.
Lancet. 2010 May 8;375(9726):1609-23. doi: 10.1016/S0140-6736(10)60518-1. Epub 2010 Apr 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验